ACC is known to downregulate miR-19 (decreased apoptosis) and miR-7 (enhanced cell viability and invasiveness) while upregulating miR-483 (increased IGF2 expression and regulation of the BBC3/PUMA protein) [171,172,173]. The gene discussed is IGF2; the disease is adrenal cortex carcinoma.